Welcome to our dedicated page for Ambev SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambev S.A. (ABEV) SEC filings page brings together the company’s disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Ambev files an annual report on Form 20-F, as highlighted in multiple press releases announcing the availability of its annual reports for successive years. These 20-F filings contain the company’s complete audited financial statements, and the press releases note that American Depositary Receipt holders may request hard copies free of charge.
In addition to its annual reports, Ambev regularly furnishes Form 6-K current reports. The examples provided include notices to shareholders about ordinary shareholders’ meetings, extracts of minutes from Board of Directors meetings, and detailed explanations of decisions to distribute dividends and interest on capital based on extraordinary balance sheets. Other 6-Ks disclose policies on executive remuneration and the grant of stock options and restricted shares, as well as a policy on hiring services related or not related to auditing, which sets conditions for engaging independent auditors and lists non-authorized services to preserve auditor independence.
Ambev also uses Form 6-K to report related party transactions, such as its agreement with its controlling shareholder Anheuser-Busch InBev SA/NV for the use of the BEES B2B digital platform, and to provide consolidated and individual forms under Article 11 of CVM Instruction 358/2002 that detail management and related persons’ transactions in Ambev shares and ADRs. These forms show initial and final positions, deliveries of restricted shares, purchases, and sales.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the key points of lengthy documents, highlight items such as dividend approvals, interest on capital distributions, insider share movements, and policy changes, and help readers navigate Ambev’s 20-F and 6-K disclosures more efficiently.
Ambev S.A. filed a consolidated report of management and related persons’ transactions in its securities for the period from April 1 to 30, 2026, in accordance with Article 11 of CVM Instruction # 44/2021.
For the board of directors’ group, common share holdings moved from 30,699,742 to 30,679,627 shares after a single renounce operation of 20,115 common shares on day 30, recorded at a price and volume of R$0.00. Associated ADR holdings for this group remained 468,040 common ADRs. For the management group, common share and ADR balances stayed unchanged at 4,753,962 common shares and 19,790 ADRs, with no transactions in the month. The fiscal council group maintained 2,500 common shares, also with no effective change despite a renounce entry showing zero quantity.
Ambev S.A. filed a Form 6-K detailing its own share transactions for April 2026 under Brazilian CVM Instruction 44/2021. The company repurchased common shares through Santander Corretora on multiple trading days, each transaction involving 2,000,000 shares at prices between R$15.2387 and R$16.1457 per share.
As a result of these purchases, Ambev’s treasury stock of common shares increased from 166,970,849 to 190,970,849 by the end of April 2026. The filing covers only the company’s positions in common shares and ADRs, with no ADRs held in treasury at month-end.
Ambev S.A. announces that its Board of Directors has approved a distribution of Interest on Own Capital (IOC) to shareholders. The payment will be made by December 31, 2026, based on holdings as of June 22, 2026 on B3 and June 24, 2026 on the NYSE. Shares and ADRs trade ex‑IOC from and including June 23, 2026. A standard 17.5% withholding income tax rate applies, subject to exemptions, immunities and tax treaties. Non‑resident shareholders seeking reduced withholding under double taxation treaties must submit documentation, including an ultimate beneficial owner form and tax residence certificate, by June 26, 2026. Ambev reiterates its focus on shareholder value and transparent disclosure.
Ambev S.A. delivered a solid first quarter of 2026, driven by pricing and mix rather than volume. Organic net revenue grew 8.1% while organic normalized EBITDA increased 10.1%, expanding the normalized EBITDA margin by 60 bps to 33.6%.
Operating cash flow reached about R$ 3.2 billion, up roughly 162% year over year, described as the strongest first-quarter operating cash performance in a decade. The company maintained net cash of about R$ 16.5 billion and reinforced shareholder returns through interest on capital payments totaling roughly R$ 1.9 billion for 2026, alongside an ongoing share buyback program.
Ambev S.A. announced that its board approved a 2026 distribution of Interest on Own Capital (IOC) to shareholders. The payment will be made by December 31, 2026, with no monetary adjustment, based on holdings as of June 22, 2026 on B3 and June 24, 2026 on the NYSE.
Shares and ADRs will trade ex-IOC from and including June 23, 2026. The standard withholding income tax rate on IOC is 17.5%, subject to tax immunities, exemptions and international treaties. Non-resident shareholders seeking treaty benefits must submit documentation, including a beneficial owner form and tax residence certificate, by June 26, 2026. Ambev highlights procedures for crediting amounts through bank accounts, depositary bank notices and fiduciary custody, and reiterates its focus on shareholder value and transparent disclosure.
Ambev S.A. reports several board and management decisions along with additional shareholder distributions. The Board elected Michel Dimitrios Doukeris as chairman and reaffirmed compensation for the Board, advisory committees and Fiscal Council for the 2026 fiscal year.
The Board appointed members and chairs for the Operations and Finance, Governance and People Committees, with terms running until the Annual General Meeting to be held in 2029, and set a new Executive Board composition effective May 4, 2026 with a unified term through December 31, 2027.
Ambev approved payment of the second tranche of interest on own capital (IOC) on July 6, 2026 at a gross R$0.0755 per share (net R$0.0642 per share), and a new IOC distribution of gross R$0.0449 per share (net R$0.0370 per share) based on an extraordinary balance sheet for the three months ended March 31, 2026. The new IOC will not be allocated to the mandatory minimum dividend for the fiscal year.
Ambev S.A. reports interim Q1 2026 results under IAS 34, showing broadly stable performance. Net sales were R$22.46 billion, almost unchanged from R$22.50 billion a year earlier, while net income edged up to R$3.89 billion from R$3.80 billion. Basic earnings per share reached R$0.2414, slightly above R$0.2358.
Operating profit rose to R$5.99 billion, supported by firm gross margins and disciplined distribution, commercial and administrative spending. Brazil remained the main contributor, with net sales of R$13.25 billion. Despite negative currency translation effects reducing equity, total equity increased to R$90.8 billion, and the group held a net cash position, with cash and cash equivalents of R$17.99 billion exceeding interest‑bearing debt.
Ambev S.A. reported the consolidated final voting results from its Ordinary and Extraordinary General Shareholders’ Meetings held on April 30, 2026. Shareholders approved the managers’ accounts and financial statements for the fiscal year ended December 31, 2025 and the proposed allocation of 2025 net profit, including re-ratification of certain 2024 reserve allocations, in line with the Management Proposal.
They set the Board of Directors at 9 effective members and 2 alternates and elected the full slate indicated by the controlling shareholders, including independent members Luciana Pires Dias and Fernanda Gemael Hoefel. The Fiscal Council size and compensation were approved, as was overall manager compensation for 2026.
At the Extraordinary Meeting, shareholders approved several bylaw amendments, including updating article 5 to reflect capital increases within authorized capital, restructuring statutory officer roles and titles, clarifying how interim dividends and interest on capital relate to the mandatory minimum dividend, and renumbering and consolidating the bylaws.
Ambev S.A. furnishes its updated bylaws, approved at an Ordinary and Extraordinary Shareholders’ Meeting held on April 30, 2026. The bylaws set the Company’s capital stock at R$58.308.213.544,96, divided into 15.763.664.889 book-entry common shares, each with one vote.
The Board of Directors may increase capital up to a limit of 19,000,000 shares, issue convertible debentures and subscription bonuses, and grant stock options under shareholder-approved plans. The document details the composition and powers of the Board of Directors, Executive Officers and the permanent Fiscal Council, dividend and interest-on-equity rules, and provides indemnification and legal defense for directors, officers, council members and certain employees, subject to reimbursement if a final court decision finds negligent or criminal conduct.